Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: MarketLine (a Datamonitor Company)
Provider: Wright Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

JAPAN TOBACCO INC and Torii Pharmaceutical Co., Ltd. File for New Drug Application for Marketing Approval of Hyperphosphatemia Remedy JTT-751 in Japan

Monday, 7 Jan 2013 01:00am EST 

JAPAN TOBACCO INC announced that it has filed a new drug application (NDA) for marketing approval of a hyperphosphatemia remedy JTT-751 in Japan. If the application is approved, Torii Pharmaceutical Co., Ltd. will be in charge of the sale of the new drug. 

Company Quote

29.5 +0.80%
29 Jul 2014